Coelho Rogerio Vivaldi

Insider Reports History

Location
Waltham, MA
Signature
/s/ Tobin Schilke, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Coelho Rogerio Vivaldi:

Company Role Class Num Shares Value Price $ Report Date Ownership
Crinetics Pharmaceuticals, Inc. Director Common Stock 21,300 $709,716 $33.32 11 Jun 2025 Direct
Viatris Inc Director Restricted Stock Units 23,660 $221,694 $9.37 06 Mar 2025 Direct
Viatris Inc Director Common Stock 21,691 $203,245 $9.37 04 Mar 2025 Direct
Viatris Inc Director Dividend Equivalent Units 0 $0 $9.37 04 Mar 2025 Direct
Crinetics Pharmaceuticals, Inc. Director Stock Option (right to buy) 10,350 11 Jun 2025 Direct
Sigilon Therapeutics, Inc. PRESIDENT AND CEO, Director Common Stock 0 $14.92 11 Aug 2023 Direct
Sigilon Therapeutics, Inc. PRESIDENT AND CEO, Director Stock Option (Right to Buy) 0 $6.64 11 Aug 2023 Direct

Insider Reports Filed by Coelho Rogerio Vivaldi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRNX Crinetics Pharmaceuticals, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 16:30
VTRS Viatris Inc 06 Mar 2025 1 $0 4 Director 10 Mar 2025, 18:00
VTRS Viatris Inc 04 Mar 2025 4 $0 4 Director 05 Mar 2025, 19:00
CRNX Crinetics Pharmaceuticals, Inc. 07 Jun 2024 2 $0 4 Director 11 Jun 2024, 16:21
VTRS Viatris Inc 03 Jun 2024 1 $0 4 Director 04 Jun 2024, 18:05
VTRS Viatris Inc 03 Jun 2024 0 $0 3 Director 04 Jun 2024, 18:00
SGTX Sigilon Therapeutics, Inc. 11 Aug 2023 2 -$26,536 4 PRESIDENT AND CEO, Director 11 Aug 2023, 16:10
SGTX Sigilon Therapeutics, Inc. 21 Jul 2023 2 +$106,359 4 PRESIDENT AND CEO, Director 24 Jul 2023, 19:44
CRNX Crinetics Pharmaceuticals, Inc. 16 Jun 2023 2 $0 4 Director 21 Jun 2023, 17:00
CRNX Crinetics Pharmaceuticals, Inc. 08 Jun 2023 1 +$110,300 4 Director 09 Jun 2023, 08:00
SGTX Sigilon Therapeutics, Inc. 28 Feb 2023 1 $0 4 PRESIDENT AND CEO, Director 01 Mar 2023, 15:43
CRNX Crinetics Pharmaceuticals, Inc. 17 Jun 2022 1 $0 4 Director 21 Jun 2022, 16:47
SGTX Sigilon Therapeutics, Inc. 18 Feb 2022 1 +$340,400 4 PRESIDENT AND CEO, Director 22 Feb 2022, 16:00
CRNX Crinetics Pharmaceuticals, Inc. 03 Jan 2022 1 $0 4/A Director 04 Apr 2022, 19:08
CRNX Crinetics Pharmaceuticals, Inc. 03 Jan 2022 0 $0 3 Director 10 Jan 2022, 15:29
SGTX Sigilon Therapeutics, Inc. 03 Jan 2022 1 +$1,212,000 4 PRESIDENT AND CEO, Director 04 Jan 2022, 15:15
SGTX Sigilon Therapeutics, Inc. 04 Nov 2021 1 $0 4 PRESIDENT AND CEO, Director 05 Nov 2021, 16:15